throbber
FDA Journal of
`
`Science and
`
`Technology
`
`I Pharmaceutical
`
`Number 2 _
`
`1995
`
`March / April
`
`Volume 49
`
`APOTEX 1041, pg. 1
`
`APOTEX 1041, pg. 1
`
`

`

`March—April 1995
`
`V01. 49, No. 2
`
`FDA Journal of
`
`Pharmaceutical Science and Technology
`EDITOR:
`Joseph B. Schwartz
`
`Philadelphia College of Pharmacy & Science
`600 South 43rd Street
`
`Philadelphia, PA 19104-4495
`Phone: (215) 596-8590
`STAFF: Susan M. McCoy, Henrietta Zimm
`
`
`CIRCULATION OFFICE:
`PDA, Inc.
`7500 Old Georgetown Rd
`Suite 620
`Bethesda, MD 20814
`Phone: (301) 986-0293
`
`ADVERTISING / CIRCULATION : Margaret Wanca
`Phone: (301) 986-0293
`
`ADVISORY BOARD
`
`Michael Akers, Eli Lilly and Co.
`Frederick J. Carleton
`
`Patrick DeLuca, University ofKentucky
`Barry Garfinkle, Merck Sharp & Dohme
`Michael Groves, University ofIllinois
`Joseph Robinson, University of Wisconsin
`Theodore Roseman, Baxter Healthcare
`
`1995 OFFICERS AND DIRECTORS
`
`Chairman:
`
`Clarence A. Kemper, Ph.D.
`Chairman-Elect: Raymond Shaw, Jr., Ph.D.
`Henry K Kwan, Ph.D.
`Secretary:
`Treasurer:
`Raymond Gabler, Ph.D.
`
`'
`
`James E. Akers, Ph.D.
`Joyce Aydlett
`Floyd Benjamin
`Peter T. Bigelow
`Joyce L. DeYoung, Ph.D.
`R. Michael Enzinger, Ph.D.
`John Geigert, Ph.D.
`Martin W. Henley
`Kunio Kawamura, Ph.D.
`Robert Morrissey, Ph.D.
`, Terry E. Munson
`Robert Myers
`Jean A. LaDouceur
`
`President: Edmund M. Fry
`
`PDA Journal of Pharmaceutical Science & Technology
`(ISSN 1076-397X) is published bimonthly by the PDA, Inc.,
`7500 Old Georgetown Rd., Suite 620, Bethesda, MD 20814.
`Subscriptions—Membership dues in the PDA, Inc., include
`an annual subscription to the Journal for each member and
`corporate representative. For an application form and informa-
`tion regarding membership, address the Association. Indus—
`trial, university and public libraries and government agencies
`may subscribe at the rate of $90.00 per year. Back issues of the
`journal are available from the Association for $15 .00 plus $1.50
`postage and handling per in stock reprint; or $30.00 plus $3.00
`postage and handling for photocopies of reprints not in stock.
`Claims—Issues lost in transit will not be replaced if claim is
`received more than 90 days from date of issue or if loss was due
`to failure to give notice of changc of address. The Association
`cannot accept responsibility for delivery outside the United
`States when shipment has been made by first-class mail.
`Second class postage paid at Bethesda, Maryland and
`additional mailing offices. Postmaster: send address changes to
`the PDA Journal of Pharmaceutical Science & Technology,
`7500 Old Georgetown Rd., Suite 620, Bethesda, MD 20814.
`‘ Printed in the USA.
`
`Formerly the
`“Journal of Parenteral Science and Technology”
`
`Copyright—FDA, Inc. 1995
`ISSN 1076-397X
`
`The FDA, Inc. and‘its editor assume no responsibility
`for the statements and opinions advanced by contribu-
`tors. Views expressed in the editorials are those of the
`author and do not necessarily represent the oflicial
`
`position of FDA, Inc.
`
`APOTEX 1041, pg. 2
`
`APOTEX 1041, pg. 2
`
`

`

`RESEARCH ARTICLE
`
`Particle Size Reduction of Emulsions by Formulation Design-11:
`Effect of Oil and Surfactant Concentration
`
`GURMUKH D. CHANANA* and BHOGI B. SHETHt
`
`Parenteral Medications Laboratories, Department of Pharmaceutics, University of Tennessee, Memphis, Tennessee
`
`ABSTRACT: The objective of this study was to investigate the effect of the concentration of surfactant and oil on
`particle size reduction and stability of oil-in-water emulsion formulations containing polyhydroxy alcohols.
`Emulsions were prepared using an emulsifier system consisting of Tween 80® and Span 80® with 5%, 10%, 15%
`and 20% soybean oil and containing 50% w lw of either propylene glycol (PG) or glycerol (GLY) in the external
`phase. At each oil concentration, four emulsions were formulated with increasing surfactant concentration to
`provide emulsions with surfactant to oil ( S I 0) ratios of 0.1, 0. 2, 0.3 and 0. 4. Three parameters were evaluated,
`particle size reduction, particle size stability upon dilution, and viscosity. It was found that increase in S I 0 ratio
`resulted in substantial decrease in particle size in all cases. But there was a difference in the particle size reduction
`pattern between PG and GLY. Increase in oil concentration at the same S I 0 ratio caused particle size reduction
`for emulsions with PG but not for emulsions with GLY. The reduction in particle size was also greater for
`emulsions containing PG. Further, particle size of emulsions containing PG was found to be stable over 24 hours
`after dilution. However, a slight increase in particle size was observed in emulsions containing GLY. It was also
`found that the viscosity of emulsions increased with an increase S I 0 ratio as well as the concentration of the oil.
`
`Introduction
`
`The use of oil-in-water emulsions as drug delivery
`systems has been widely recognized, and considerable
`research has been focused on emulsions in recent years.
`These systems can be used for the delivery of poorly
`water-soluble drugs via the parenteral route (1). The
`typical method of preparation of intravenous 0 IW
`emulsions requires the use of high shear. or high energy
`equipment (2-4). An alternate method for particle size
`reduction is by formulation design. In this method, a
`fourth component, referred to as the cosurfactant, is
`added to emulsion formulations to achieve a decrease in
`particle size (5, 6).
`In a previous study, we reported on the effect of the
`addition of glycerol (GLY) and propylene glycol (PG)
`on particle size reduction of oil-in-water emulsions of
`soybean oil (7). These polyhydroxy alcohols appeared to
`act as cosurfactants when added at concentrations
`ranging from 30% to 70% in the external phase, causing
`a substantial reduction in the particle size. The mini(cid:173)
`mum particle size obtained in the study was approxi(cid:173)
`mately 2.0 ,_..,m. However, the particle size of emulsions
`intended for intravenous administration needs to be
`below 1 ,_..,m (8).
`Therefore, it was an objective of this study to investi(cid:173)
`gate if further particle size reduction could be achieved
`
`Received November 22, 1993. Accepted for publication September 16,
`1994.
`* Present Address-American Drug Development Inc., 9100A Yellow
`Brick Road, Baltimore, MD 21237.
`t Author to whom correspondence should be addressed: 38163.
`
`by either decreasing the amount of oil or increasing the
`amount of surfactant. Soybean oil emulsions were formu(cid:173)
`lated containing 50% w lw GL Y or PG in the external
`phase. This was the concentration of polyhydroxy alco(cid:173)
`hol at which maximum particle size reduction was
`observed (7). Emulsions were prepared containing in(cid:173)
`creasing oil concentration as well as increasing surfac(cid:173)
`tant concentration. The parameters evaluated were
`particle size reduction, particle size stability upon dilu(cid:173)
`tion, and viscosity. Particle size stability was evaluated in
`emulsions diluted with commonly used Large Volume
`Parenteral Solutions (L VPs ).
`
`Materials and Equipment
`
`Glycerol ( GL Y) and propylene glycol (PG) were
`obtained from J. T. Baker (Phillipsburg, NJ). Soybean
`oil was obtained from Croda Inc. (Mill Hall, PA).
`Polyoxyethylene sorbitan monooleate (Tween 80®) and
`sorbitan monooleate (Span 80®) were obtained from
`Emulsion Engineering, Inc. (Sanford, FL). Sterile Wa(cid:173)
`ter for Injection, USP (SWFI) was obtained from Abbott
`Laboratories (North Chicago, IL), 10% Mannitol Injec(cid:173)
`tion, USP was obtained from American McGaw (Irvine,
`CA) and 0.9% Sodium Chloride Injection was obtained
`from Travenol Laboratories Inc. (Deerfield, IL). A
`single lot of each material was used in preparation of all
`emulsions. Equipment used to make emulsions in~
`eluded: propeller mixer, Model RW 20 DZM, (Ika(cid:173)
`Werk, Germany), and homogenizer, Model Omni 2000,
`(Omni International, CT). Particle size was determined
`with a Horiba Particle Size Analyzer, Model CAPA 700,
`(Horiba Corporation, Irvine, CA). Viscosity was mea-
`
`Vol. 49, No. 2 I March-April1995
`
`71
`
`APOTEX 1041, pg. 3
`
`

`

`sured using a Brookfield Cone and Plate Viscometer,
`Model DV-11, (Brookfield Engineering Laboratories,
`Stoughton, MA).
`
`5
`
`4
`
`No Polyhydroxy Alcohol
`in External Phase
`
`--o-- GL Y Emulsions
`--..- PG Emulsions
`
`Methods
`
`In a study reported previously, it was found that the
`emulsifier blend with HLB value of 8.0 gave the most
`stable emulsion (7). It was also found that emulsifier
`concentration of 2% w /w (10 percent of the oil phase)
`gave the minimum particle size. Increase in emulsifier
`concentration beyond 2% w /w did not result in further
`decrease in the particle size of the emulsion. Therefore,
`this concentration of the emulsifier blend, correspond(cid:173)
`ing to surfactant to oil (S/0) ratio of 0.1, was chosen as
`the minimum concentration used in this study. Formula(cid:173)
`tions with higher surfactant concentrations were pre(cid:173)
`pared to provide emulsions with,S/0 ratios ranging from
`0.1-0.4.
`We had also reported that the particle size of soybean
`oil decreased with an increase in polyhydroxy alcohol
`concentration in the external phase (7). It was found
`that poly hydroxy alcohol level of 50% w /w in the
`external phase caused maximum reduction in particle
`size. The particle size of emulsions containing 50% w /w
`of either GLY or PG was found to be approximately 2.0
`J.Lm. Therefore, this level of polyhydroxy alcohol was
`selected.
`A stable base 0 /W emulsion without any poly hydroxy
`alcohol was first formulated. This base emulsion was
`formulated to contain 20% w /w soybean oil and a
`surfactant system consisting of an emulsifier blend of
`35% Tween 80® and 65% Span 80®. The amount of
`emulsifier blend used was 10% of the oil phase, giving an
`S/0 ratio of 0.1. The procedures used in formulation
`development have been previously described (7). Four
`
`TABLE I
`Formulations Prepared to Study the Effect of Surfactant and
`Oil Concentrations on the Particle Size and Viscosity of
`Emulsions Containing Propylene Glycol or Glycerol
`
`Surfactant Concentration (% w/w of oil phase)
`
`Figure 1-Effect of surfactant concentration on the particle size of
`0/W emulsions with 20% w/w soybean oil.
`
`series of emulsions were prepared with this emulsifier
`blend containing 5%, 10%, 15% and 20% w/w oil,
`respectively. For each series of emulsions, four formula(cid:173)
`tions were prepared at each oil concentration with
`increasing amounts of the emulsifier blend. The increase
`in emulsifier concentration was designed to provide S/0
`ratios of 0.1, 0.2, 0.3 and 0.4, respectively. Table I shows
`the sixteen emulsions prepared for this investigation.
`The method of preparation of emulsions was as follows:
`the oil phase containing the surfactants, heated to 60°C,
`was added to aqueous phase (50% w /w poly hydroxy
`alcohol solution) heated to 60oC and mixed with the
`homogenizer at 30,000 rpm for 5 minutes. Particle size
`determination of the emulsions was carried out within
`24 hours after their preparation. The procedure used in
`the particle size determination has been described
`previously (7).
`The investigation of particle size stability of admix(cid:173)
`tures of emulsions with L VPs was done with 20%
`soybean oil emulsion at two S/0 ratios of 0.1 and 0.4,
`respectively. The following procedure was used: the
`sample tube containing the emulsion was gently inverted
`10 times to get a homogeneous sample. A sample of 2
`
`Ingredient Concentration, % w /w
`
`Soybean Tween
`Oil
`SO®
`
`Span PGn or
`GLYh Water
`SO®
`
`3
`
`Surfactant
`to Oil (S/0)
`Ratio
`0.1
`
`0.2
`
`0.3
`
`0.4
`
`5
`10
`15
`20
`5
`10
`15
`20
`5
`10
`15
`20
`5
`10
`15
`20
`
`0.17
`0.35
`0.50
`0.70
`0.35
`0.70
`1.05
`1.40
`0.50
`1.05
`1.60
`2.10
`0.70
`1.40
`2.10
`2.80
`
`0.33
`0.65
`1.00
`1.30
`0.65
`1.30
`1.95
`2.60
`1.00
`1.95
`2.90
`3.90
`1.30
`2.60
`3.90
`5.20
`
`47.25
`47.25
`45.50
`45.50
`41.75
`41.75
`39.00
`39.00
`47.00
`47.00
`44.00
`44.00
`41.00
`41.00
`38.00
`38.00
`46.75
`46.75
`. 43.50
`43.50
`40.25
`40.25
`37.00
`37.00
`46.50 . 46.50
`43.00
`43.00
`39.50
`39.50
`36.00
`36.00
`
`a Propylene Glycol.
`b Glycerol.
`
`72
`
`i:
`3-
`0
`>
`
`= :0
`::E
`
`'1.1
`
`SlQ RDtiQ
`
`-o- 0.2
`
`--o- 0.4
`
`----- 0.1
`---- 0.3
`" ~ =
`<====
`
`0
`
`0
`
`5
`
`10
`
`15
`
`20
`
`25
`
`Oil Concentration (% w/w)
`Figure 2-E.ffect of surfactant and oil concentrations on the particle
`s1ze of soybean oil emulsions containing 50% w /w glyc-
`erol.
`
`PDA Journal of Pharmaceutical Science & Technology
`
`APOTEX 1041, pg. 4
`
`

`

`3
`
`2
`
`e
`
`~
`0
`;...
`0
`
`= tG :a
`
`Cll
`~
`
`S/0 Ratio
`
`• 0.1
`• 0.3
`
`D 0.2
`
`0 0.4
`
`o+---~----~--~----~--~--~
`0
`10
`20
`30
`
`Oil Concentration (% w/w)
`Figure 3-Effect of surfactant and oil concentrations on the particle
`size of soybean oil emulsions containing 50% w /w propyl(cid:173)
`ene glycol.
`
`grams of this emulsion was added to 18 grams of the
`LVP solution to make a 1:10 dilution. The particle size
`was measured before dilution, immediately after dilu(cid:173)
`tion, and 1 hour, 6 hours and 24 hours after dilution. The
`LVPs used were Sterile Water for Injection (SWFI),
`10% Mannitol Solution and 0.9% Sodium Chloride
`Injection. These solutions are commonly used in the
`preparation of intravenous admixtures.
`Viscosity values of emulsions and of aqueous solutions
`corresponding in composition to the respective external
`phase of each emulsion were also determined. The
`viscosity measurements were made with a Brookfield
`Model DV II cone and plate viscometer at 25°C.
`
`Results and Discussion
`
`Effect of Increasing Surfactant Concentration ( S I 0 ratio)
`
`The effect of increasing surfactant concentration, with
`a corresponding increase in the S/0 ratio, on the
`particle size reduction of emulsions containing 20% w /w
`oil is shown in Figure 1. The effect of 50% w /w
`polyhydroxy alcohol concentration on the particle size
`
`can also be noted in Figure 1. The effect of increasing
`S I 0 ratio on particle size at four concentrations of oil is
`given in Figure 2 for emulsions with GL Y and in Figure
`3 for emulsions with PG. It is evident that increasing the
`S/0 ratio caused further decrease in particle size.
`Increasing the S/0 ratio from 0.1 to 0.4 resulted in a
`four-fold decrease in the particle size. The particle size
`of emulsions with GLY decreased from about 2.1 J.Lm to
`about 0.5 J,Lm. The particle size reduction effect is
`similar, but more pronounced, for emulsions with PG.
`It was found that particle size reduction to below 1 J.Lm
`could be achieved by increasing the surfactant concentra(cid:173)
`tion above a critical surfactant concentration (CSC) for
`emulsions containing PG or GL Y. The CSC required for
`emulsions with 50% w /wPG and 20% w /w oil was found
`to occur at a surfactant concentration at 0.2 S/0 ratio.
`The CSC required for emulsions with 50% w /w PG and
`lower oil concentrations was at surfactant concentra(cid:173)
`tions corresponding to 0.3 S/0 ratio. On the other hand,
`the esc was at 0.3 s I 0 ratio for all oil concentrations
`for emulsions with 50% w /w GL Y. This indicates that
`PG acts as a more effective cosurfactant than GL Y at
`the higher oil concentration.
`Several theories on the reduction of particle size and
`formation of microemulsions due to the addition of
`cosurfactant have been proposed (9-14). Two of the
`predominant theories include reduction of interfacial
`tension (9-14) and solubilization of oil in surfactant
`micelles (15). The addition of polyhydroxy alcohols in
`the external phase can cause changes in the interfacial
`properties, since the surface tensions of both PG ( 40.1
`dynes/em) and GLY (63.4 dynes/em) are considerably
`lower than that of water (72.8 dynes/em) at 20°C. It is
`likely that the interfacial tensions of polyhydroxy alcohol
`solutions (that make up the external phase) and the oil
`will be significantly lower than between water and oil.
`Hence, it is likely that the predominant factor in the
`reduction of particle size is the lower interfacial tension.
`This mechanism is also supported by other studies
`reported for microemulsions. Prince (13) proposed that
`the formation of small droplets in microemulsions was in
`part due to a reduction in the interfacial tension of oil
`and water, in the presence of a cosurfactant. Rucken(cid:173)
`stein and Chi (14) also explained the formation and
`stability of microemulsions using the surface tension
`
`TABLE II
`Particle Size Stability of Emulsions Containing Propylene Glycol After Dilution with Large Volume Parenteral Solutions
`
`10% Mannitol
`
`0.9% Sodium Chloride Injection
`
`Sterile Water For Inj. (SWFI)
`
`Particle Size, Median-Dvol (f.Lm) ± SDa
`
`A
`
`Time
`Before dilution
`After dilution
`After 1 hour
`After 6 hours
`After 24 hours
`
`A
`A
`B
`B
`1.8 ± 1.3
`0.6'± 0.6
`1.8 ± 1.3
`0.6 ± 0.6
`1.8 ± 1.3
`1.4 ± 1.0
`1.2 ± 0.9
`0.4 ± 0.4
`1.6 ± 1.1
`0.4 ± 0.5
`1.4 ± 1.2
`1.4 ± 1.0
`0.4 ± 0.4
`1.6 ± 1.0
`0.4 ± 0.4
`1.4 ± 1.2
`1.5 ± 1.2
`0.4 ± 0.3
`0.4 ± 0.4
`1.6 ± 1.2
`1.5 ± 1.3
`1.5 ± 1.1
`0.4 ± 0.3
`1.1 ± 0.7
`0.4 ± 0.4
`A: Emulsions containing S/0 ratio of0.1. B: Emulsions containing S/0 ratio of 0.4. Emulsions contained 20% oil and 50% propylene glycol in the
`external phase.
`a Standard Deviation. The particle size of three separate samples was measured for each emulsion.
`
`B
`0.6 ± 0.6
`0.4 ± 0.4
`0.4 ± 0.4
`0.4 ± 0.4
`0.4 ± 0.4
`
`Vol. 49, No. 2 I March-April1995
`
`73
`
`APOTEX 1041, pg. 5
`
`

`

`TABLE Ill
`Particle Size Stability of Emulsions Containing Glycerol After Dilution with Large Volume Parenteral Solutions
`
`Particle Size, Median-Dvol (f.Lm) ± SDa
`
`10% Mannitol
`
`0.9% Sodium Chloride Injection
`
`Sterile Water For lnj. (SWFI)
`
`Time
`Before dilution
`Mter dilution
`Mter 1 hour
`Mter 6 hours
`After 24 hours
`
`A
`2.4 ± 1.3
`2.8 ± 1.7
`2.5 ± 1.8
`2.6 ± 1.8
`2.6 ± 1.5
`
`B
`0.6 ± 0.6
`0.8 ± 1.0
`0.8 ± 1.2
`0.8 ± 1.0
`0.9 ± 1.0
`
`A
`2.4 ± 1.3
`2.7 ± 1.6
`2.6 ± 1.5
`2.6 ± 1.3
`2.6 ± 1.3
`
`B
`0.6 ± 0.6
`0.8 ± 0.9'
`0.8 ± 1.0
`0.7 ± 0.9
`0.8 ± 1.3
`
`A
`2.4 ± 1.3
`2.2 ± 1.4
`2.7 ± 1.5
`2.6 ± 1.4
`2.6 ± 1.4
`
`B
`0.6 ± 0.6
`1.1 ± 1.1
`1.0 ± 1.3
`1.5 ± 1.3
`1.1 ± 1.2
`
`A: Emulsions containing S/0 ratio of 0.1. B: Emulsions containing S/0 ratio of 0.4. Emulsions contained 20 percent oil and 50 percent glycerol in
`the external phase.
`a Standard Deviation. The particle size of three separate samples was measured for each emulsion.
`
`lowering concept, including the dispersion entropy of
`the droplets and the reduction of chemical potential of
`· the surfactant 'and the cosurfactant in the bulk phase by
`adsorption at the interface. It is thought that the
`mechanism of particle size reduction due to addition of
`the polyhydroxy alcohol should be similar. Decrease in
`the interfacial tensions between oil and aqueous solu(cid:173)
`tions of polyhydroxy alcohols have been reported by
`Magdasi and Frank (16).
`The decrease in particle size observed, with an in(cid:173)
`crease in the surfactant concentration, may also be the
`result of more surfactant being available to stabilize the
`increased interfacial area created during the mixing
`process. In the absence of polyhydroxy alcohol, much
`more energy may be required to create a similar increase
`in the interfacial area due to a higher interfacial tension.
`The differences observed in the effects of PG and
`GL Y on the reduction of particle size may be due to the
`nature of the polyhydroxy alcohols. PG is dihydroxy
`alcohol with a significantly lower surface tension ( 40
`dynes/em), while GLY is a trihydroxy alcohol with a
`surface tension of 63.4 dynes/em. Hence, it is possible
`that the interfacial tension between the oil and aqueous
`solution of PG may be lower than that between the oil
`and aqueous solution of GL Y. Also, the fewer number
`of hydroxyl groups in PG may result in an increased
`presence of PG at the interface that may also result in
`increased hydrogen bonding with the polar regions of
`the surfactants.
`
`Effect of Oil Concentration
`
`It was observed that there was a difference in the
`effect of oil concentration on particle size reduction of
`the emulsions containing PG and GL Y. This is shown in
`Figure 2 for emulsions containing GLY as cosurfactant
`and in Figure 3 for emulsions containing PG. In emul(cid:173)
`sions containing GLY as the cosurfactant, the particle
`size remained essentially similar at all S I 0 ratios. But
`particle size decreased with an increase in the oil
`concentration at all S I 0 ratios in emulsions containing
`PG. These results also indicate that PG acts as a better
`cosurfactant than GLY. It is unlikely that the reduction
`in particle size observed was due to solubilization of the
`oil in sudactant and polyhydroxy alcohol because both
`PG and GL Y are immiscible with fixed oils.
`
`Effect of Dilution on Particle Size Stability
`
`The particle size stability of emulsions upon dilutions
`with selected L VPs is shown in Tables II and III. The
`emulsions with S/0 ratio of 0.1 and 0.4 were selected for
`the study. It was found that emulsions containing PG
`were very stable, showing no increase in particle size. A
`slight increase in particle size was observed for emul(cid:173)
`sions with GL Y. Thus, the differences in the effect of PG
`and GLY can also be seen in particle size stability
`results. These results also indicate that PG is a better
`cosurfactant than GL Y. The differences in the stability
`of the emulsion droplets also indicate an increased
`presence of PG at the interface due to possible increase
`in hydrogen bonding with the polar regions of the
`surfactants.
`
`Effect on Emulsion Viscosity
`
`Measurements were made of the viscosity of emul(cid:173)
`sions and the corresponding external aqueous phase.
`Solutions containing 50% of the polyhydroxy alcohol
`and amounts of Tween 80® corresponding to the concen(cid:173)
`trations in the respective emulsions were prepared as
`samples representative of the external phase. These
`results are shown in Figures 4 and 5. The viscosity of
`
`Soybean Oil Conrentratjon (% w/w)
`
`- - - 5%
`-o- 10%
`--o- 15%
`----- 20%
`
`30
`
`20
`
`10
`
`~
`g.
`~
`.t>
`·;
`Q
`Col
`
`til ;;
`
`0+---~-,--~--~--~~~~---r--~~
`0.0
`0.1
`0.3
`0.4
`0.2
`0.5
`
`S/0 Ratio
`Figure 4-Effect of surfactant to oil (S/0) ratio on the viscosity of
`soybean oil emulsions containing 50% w/w propylene
`glycol.
`
`74
`
`PDA Journal of Pharmaceutical Science & Technology
`
`APOTEX 1041, pg. 6
`
`

`

`30
`
`20
`
`10
`
`,-.,
`
`Ill =-~
`
`~
`'iil
`Q
`u
`
`Ill >
`
`Soybean Oil Cone. (% w/w)
`
`--- 5%
`
`-o- 10%
`
`•
`
`Soybean Oil Concentration (% w/w)
`
`--- 5%
`
`-o- 10%
`-o-
`--.-
`
`30
`
`,-.,
`Ill
`=..
`~ 20
`~
`·~
`Q
`u
`
`Ill >
`= Q
`10 = e
`'iil
`
`1';1:;:1
`
`o+---~--r-~~~--~--~--~--~--~~
`0.0
`0.1
`0.4
`0.2
`0.3
`0.5
`S/0 Ratio
`Figure 5-Effect of surfactant to oil (S/0) ratio on the viscosity of
`soybean oil emulsions containing 50% w /w glycerol.
`
`0+------------r----~----~------~--~
`5.0
`5.5
`6.5
`6.0
`External Phase Viscosity (cps)
`Figure ?-Relationship between the external phase viscosity and
`viscosity of emulsions with 50% w /w propylene glycol.
`
`emulsions was affected by the concentration of oil as
`well as surfactant. The viscosity of emulsions increased
`with an increase in surfactant concentration as might be
`expected, but the effect was relatively modest at lower
`concentrations of oil and surfactant.
`The viscosity increase was substantially higher for
`emulsions containing 20% w /w oil than for emulsions
`with lower oil concentrations. In addition, the emulsions
`with GL Y had higher viscosities than corresponding
`emulsions with PG at 20% w /w oil concentration. This
`effect was more pronounced at S/0 ratios of 0.3 and 0.4.
`A similar pattern was also observed for the viscosities of
`the corresponding aqueous external phase formulations.
`The viscosity of the solution containing GL Y was consis(cid:173)
`tently higher than the viscosity of the PG solutions above
`Tween 80® concentration of 1% w /w. This concentra(cid:173)
`tion of Tween 80® corresponds to the amount of- this
`surfactant required to provide S/0 ratios of 0.3 and
`higher. This viscosity effect is thought to be due to
`increase in the total amount of hydrophilic surfactant in
`the emulsion. These findings are similar to results
`
`30
`
`Soybean Oil Concentration (% w/w)
`
`- - 5%
`--o- 10%
`-o- 15%
`----- 20%
`
`o+---~----.---~--~----~--~--~~~
`5.5
`6.5
`6.0
`5.0
`7.0
`External Phase Viscosity (cps)
`
`Figure 6-Relationship between the external phase viscosity and
`viscosity of emulsions with 50% w/w glycerol.
`
`reported in an earlier studies (7). The relationship
`between the viscosity of emulsions and the viscosity of
`the external phase is shown in Figures 6 and 7.
`
`Conclusions
`
`Further reduction in the particle size (below 1 1-1m) of
`emulsions containing GL Y and PG can be achieved with
`increase in surfactant concentration relative to the
`amount of oil above a minimum level referred to as the
`critical surfactant concentration ( CSC). The value of
`esc can be expressed in terms of the surfactant to oil
`(S/0) ratio for emulsions. This reduction in particle size
`is thought to be a result in the decrease of interfacial
`tension of oil and water. The lower S/0 ratio required to
`reach the CSC for emulsions with PG and 20% w /w oil
`suggest that PG is more effective as a cosurfactant than
`GLY. The particle size stability upon dilution of the
`emulsions also shows that PG is a better cosurfactant
`than GLY. It also indicates that the interfacial film of·
`droplets of emulsions containing PG remains strong and
`does not coalesce. The increase in emulsion viscosity
`with an increase in S/0 ratio is largely due to the
`increase in total amount of hydrophilic surfactant.
`
`References
`
`1. R. A. Prankerd and V. J. Stella, "The use of oil-in-water emulsions
`as a vehicle for parenteral drug administration," J. Parenter. Sci.
`Techno!. 44 (3), 139-149 (1990).
`2. D. M. Lidgate, R. C. Fu, and X. X. Fleitman, "Using a microfiuid(cid:173)
`izer to manufacture emulsions," BioPharm., 28-33 (Oct. 1989).
`3. D. M. Higgins and D. M. Skauen, "Influence of power on quality
`of emulsions prepared by ultrasound," J. Pharm. Sci., 61 (10),
`1567-70 (1972).
`4. J. B. Boyett and C. W. Davis, "Injectable emulsions and suspen(cid:173)
`sions," Pharmaceutical Dosage Forms: Disperse Systems, (H. A.
`Lieberman, M. M. Reiger, G. S. Banker, eds.), 2, 379-414 (1989).
`5. A. Jayakrishnan, K. Kalaiarasi, and D. 0. Shah, "Microemulsions:
`evolving technology for cosmetic applications," J. Soc. Cosmet.
`Chern., 34, 335-350 (1984).
`6. H. N. Bhargava, A. Narurkar, and L. M. Lieb, "Using microemul(cid:173)
`sions for drug delivery," Pharm. Techno!., 46-54 (March 1987).
`7. G. D. Chanana and B. B. Sheth, "Particle size reduction of
`emulsions by formulation design-I: effect of polyhydroxy alco(cid:173)
`hols," J. Parenter. Sci. Techno!. 47(3), 130 (1993).
`
`Vol. 49, No. 2 I March-April 1995
`
`75
`
`APOTEX 1041, pg. 7
`
`

`

`8. P. P. DeLuca and J. C. Boylan, "Formulation of small volume
`parenterals," Pharmaceutical Dosage Forms: Parenteral Medica(cid:173)
`tions, (K. E. Avis, L. Lachman, and H. A. Lieberman, eds.) 1, 174
`(1984).
`9. T. P. Hoar and J. H. Schulman, "Transparent water-in-oil disper(cid:173)
`sions: the oleopathic hydro-micelle," Nature, 152, 102-103, (1943).
`10. J. H. Schulman and D. P. Riley, "X-ray investigation of the
`structure of transparent oil-water disperse systems. I," J. Colloid
`Sci., 3, 383-405 (1948).
`11. J. H. Schulman and J. A. Friend, "Light scattering investigation of
`the structure of transparent oil-water disperse systems. II," J.
`Colloid Sci., 4, 497-509 (1949).
`
`12. S. E. Friberg and R. L. Venable, Encyclopedia of Emulsion
`Technology, (Becher, P., ed.), Marcel Decker, Inc. New York, 3
`(1988).
`13. L. M. Prince, "A theory of aqueous emulsions, I. Negative interfa(cid:173)
`cial tension at the oil/water interface," J. Colloid lntetface Sci., 23,
`165 (1967).
`14. E. Ruckenstein and J. Chi, "Stability of microemulsions," J. Chern
`Soc., Faraday Trans. 2 (71), 1690 (1975).
`15. K. Shinoda and S. E. Friberg, Emulsions and Solubilization,
`Wiley-Interscience Publication, New York, 7 (1984).
`16. S. Magdassi and S. G. Frank, "Formation of oil in glycerol/water
`emulsions," J. Disp. Sci. Techno!., 7 (5), 599-612 (1988).
`
`76
`
`PDA Journal of Pharmaceutical Science & Technology
`
`APOTEX 1041, pg. 8
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket